Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To study the cost utility analysis of Erythropoietin (EPO) for maintaining the different hemoglobin (Hb) target levels in anemic hemodialysis patient in routine clinical practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Patients use EPO at least 6 months with titration of EPO therapy is permitted

Exclusion Criteria:

• Patients under 18 years old.

• Patients who have blood transfusion for anemic treatment within 6 months before EPO treatment and before the study starts

• Patients who change the modality of dialysis

• Patients who switch to other anemia treatment method between the study

• Patients who cannot answer the questionnaire and are not willing to participate in the study